Marisa J L Aitken

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 4

Top Topics

Acute Lymphoblastic Leukemia

Top Venues

Antioxidants (Basel, Switzerland)

American journal of hematology

Molecular cancer therapeutics

Therapeutic advances in hematology

The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences

United States

PHD :: Immunology

University at Buffalo

United States

BSC :: Pharmacology & Toxicology

Publications

Sankaranarayan Kannan, Mary E Irwin, Shelley M Herbrich, Tiewei Cheng, LaNisha L Patterson, Marisa J L Aitken, Kapil Bhalla, M James You, Marina Konopleva, Patrick A Zweidler-McKay, Joya Chandra
Targeting the NRF2/HO-1 Antioxidant Pathway in FLT3-ITD-Positive AML Enhances Therapy Efficacy. Antioxidants (Basel, Switzerland) 11 (4) (2022)
Marisa J L Aitken, Christopher B Benton, Feng Wang, Jianhua Zhang, Shelley M Herbrich, Koichi Takahashi, Carlos E Bueso-Ramos, Nicholas James Short
Thirty-three years later: Two distinct cases of acute lymphoblastic leukemia in one patient. American journal of hematology 95 (9) (2020)
Marisa J L Aitken, Hun J Lee, Sean M Post
Emerging treatment options for patients with p53-pathway-deficient CLL. Therapeutic advances in hematology 10 (2019)
Sankaranarayanan Kannan, Marisa J L Aitken, Shelley M Herbrich, Leonard S Golfman, Mandy G Hall, Duncan H Mak, Jared K Burks, Guangchun Song, Marina Konopleva, Charles G Mullighan, Joya Chandra, Patrick A Zweidler-McKay
Antileukemia Effects of Notch-Mediated Inhibition of Oncogenic PLK1 in B-Cell Acute Lymphoblastic Leukemia. Molecular cancer therapeutics 18 (9) (2019)